FDA Approves Melanoma BRAF Companion Test - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

FDA Approves Melanoma BRAF Companion Test

The assay is indicated to identify patients with advanced melanoma who have BRAF V600E or BRAF V600K variants and may benefit from FDA-approved targeted therapies.

  • By

  • Kathryn Wighton

  • August 10, 2026

  • 1 min

Share

Original Source(s)

FDA Approves Melanoma BRAF Companion Test

  • by Kathryn Wighton

  • August 10, 2026

Related Content

Sunscreen Myths Draw TikTok Engagement

Health-related critiques of sunscreen were uncommon, but videos containing critique drew more audience interaction than promotion-only videos.

Where Are Adults Getting Sunburned?

Water-related activities were the most commonly reported setting for recent sunburn, while more than one-half of respondents reported sunscreen use at the time of their most recent sunburn.

Out“FOX”ing cancer: the implications of FOXC2 as a putative predictive biomarker for cancer immunotherapy